INBP Stock Overview
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Integrated BioPharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.21 |
| 52 Week High | US$0.40 |
| 52 Week Low | US$0.17 |
| Beta | 0.51 |
| 1 Month Change | -1.60% |
| 3 Month Change | n/a |
| 1 Year Change | -43.38% |
| 3 Year Change | -80.28% |
| 5 Year Change | 43.33% |
| Change since IPO | -96.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| INBP | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -2.3% | -4.0% | -1.7% |
| 1Y | -43.4% | -34.3% | 22.9% |
Return vs Industry: INBP underperformed the US Personal Products industry which returned -34.3% over the past year.
Return vs Market: INBP underperformed the US Market which returned 22.9% over the past year.
Price Volatility
| INBP volatility | |
|---|---|
| INBP Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 9.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: INBP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine INBP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 141 | Riva Sheppard | www.ibiopharma.com |
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Integrated BioPharma, Inc. Fundamentals Summary
| INBP fundamental statistics | |
|---|---|
| Market cap | US$6.47m |
| Earnings (TTM) | -US$385.00k |
| Revenue (TTM) | US$50.52m |
0.1x
P/S Ratio-16.8x
P/E RatioIs INBP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INBP income statement (TTM) | |
|---|---|
| Revenue | US$50.52m |
| Cost of Revenue | US$47.17m |
| Gross Profit | US$3.35m |
| Other Expenses | US$3.73m |
| Earnings | -US$385.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 6.62% |
| Net Profit Margin | -0.76% |
| Debt/Equity Ratio | 0% |
How did INBP perform over the long term?
See historical performance and comparison